U2Bio CO. LTD. announced a private placement of sixth registered unguaranteed private convertible bonds with MaC Fund and L.P. for gross proceeds of KRW 1,500,000,000 on August 9, 2016. The bonds will be issued at par. The bonds will mature on August 9, 2019. The bonds will carry no coupon and yield to maturity of 3%. The bonds will be 100% convertible into common shares of the company at a fixed conversion price of KRW 20,000 per share from August 10, 2017 to August 9, 2019. The bonds are subscribed. The board of directors of the company approved the transaction. The payment date is August 10, 2016.